January 23, 2018 / 1:05 PM / a month ago

BRIEF-Cantargia: European Patent For Haematological Cancers Remains In Force

Jan 23 (Reuters) - CANTARGIA AB:

* CANTARGIA‘S EUROPEAN PATENT FOR HAEMATOLOGICAL CANCERS REMAINS IN FORCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below